155 related articles for article (PubMed ID: 28886050)
1. Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.
Davies J; Li SQ; Tong SY; Baird RW; Beaman M; Higgins G; Cowie BC; Condon JR; Davis JS
PLoS One; 2017; 12(9):e0184082. PubMed ID: 28886050
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition.
Qama A; Allard N; Cowie B; Davis JS; Davies J
Intern Med J; 2021 Jun; 51(6):910-922. PubMed ID: 32975893
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia.
Wood N; Warlow M; Quinn H; Selvey C; Lum G; McIntyre P; Kaldor J
Aust N Z J Public Health; 2008 Jun; 32(3):272-5. PubMed ID: 18578828
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
Davaalkham D; Ojima T; Nymadawa P; Tsend N; Lkhagvasuren T; Wiersma S; Uehara R; Watanabe M; Oki I; Nakamura Y
Pediatr Int; 2007 Jun; 49(3):368-74. PubMed ID: 17532838
[TBL] [Abstract][Full Text] [Related]
5. Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.
Bhattacharya H; Bhattacharya D; Ghosal SR; Roy S; Sugunan AP
Indian J Med Res; 2015 May; 141(5):653-61. PubMed ID: 26139785
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
Wang WL; Shu ZJ; Zhou LX; Zhao YR
Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
[TBL] [Abstract][Full Text] [Related]
7. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
[TBL] [Abstract][Full Text] [Related]
8. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.
Chen CL; Yang JY; Lin SF; Sun CA; Bai CH; You SL; Chen CJ; Kao JH; Chen PJ; Chen DS
J Hepatol; 2015 Aug; 63(2):354-63. PubMed ID: 25795588
[TBL] [Abstract][Full Text] [Related]
9. Minimization of hepatitis B infection by a 25-year universal vaccination program.
Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
[TBL] [Abstract][Full Text] [Related]
10. The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on.
Liu B; Guthridge S; Li SQ; Markey P; Krause V; McIntyre P; Sullivan E; Ward J; Wood N; Kaldor JM
Vaccine; 2012 Nov; 30(50):7309-14. PubMed ID: 23036497
[TBL] [Abstract][Full Text] [Related]
11. HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study.
Huang CF; Dai CY; Chuang WL; Ho CK; Wu TC; Hou NJ; Wang CL; Hsieh MY; Huang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
Prev Med; 2009 Apr; 48(4):397-400. PubMed ID: 19463479
[TBL] [Abstract][Full Text] [Related]
12. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
13. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
14. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiological study of hepatitis B virus markers in Japan.
Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of Hepatitis B Virus Infection in Native and Immigrant Pregnant Women: A 20-Year Retrospective Study in Taiwan.
Lin CC; Shih CT; Lee CH; Ku MK; Huang YL
Am J Trop Med Hyg; 2019 Oct; 101(4):899-904. PubMed ID: 31392948
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and human T-cell lymphotropic virus type 1 co-infection in the Northern Territory, Australia.
Marr I; Davies J; Baird RW
Int J Infect Dis; 2017 May; 58():90-95. PubMed ID: 28315754
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan.
Chen SM; Kung CM; Yang WJ; Wang HL
J Clin Virol; 2011 Sep; 52(1):11-6. PubMed ID: 21767983
[TBL] [Abstract][Full Text] [Related]
20. Trends in the prevalence of hepatitis B infection among women giving birth in New South Wales.
Deng L; Reekie J; Ward JS; Hayen A; Kaldor JM; Kong M; Hunt JM; Liu B
Med J Aust; 2017 Apr; 206(7):301-305. PubMed ID: 28403761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
